{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T22:25:21Z","timestamp":1786227921745,"version":"build-2736575974"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022JY9CPX"],"award-info":[{"award-number":["2022JY9CPX"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["20229ZA2YF"],"award-info":[{"award-number":["20229ZA2YF"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012032","name":"Fondazione Romeo ed Enrica Invernizzi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RF-2021-12372897"],"award-info":[{"award-number":["RF-2021-12372897"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.metabol.2025.156471","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:18:55Z","timestamp":1766017135000},"page":"156471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Metabolic and immune dysfunction at the crossroads between type 1 diabetes and neurodegeneration"],"prefix":"10.1016","volume":"176","author":[{"given":"Francesca","family":"D'Addio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Bucciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Lunati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fiorina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2025.156471_bb0005","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2025.156471_bb0010","article-title":"Autonomic diabetic neuropathies: a brief overview","volume":"206","author":"Pop-Busui","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2025.156471_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101979","article-title":"Antidiabetic agents as a novel treatment for Alzheimer\u2019s and Parkinson\u2019s disease","volume":"89","author":"Nowell","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.metabol.2025.156471_bb0020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2025.156471_bb0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01257917","article-title":"Pathological changes in the central and peripheral nervous system of young long-term diabetics: I. Diabetic encephalopathy","volume":"1","author":"Reske-Nielsen","year":"1966","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2025.156471_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2024-004024","article-title":"Increased incidence of neurodegenerative diseases in Finnish individuals with type 1 diabetes","volume":"12","author":"Satuli-Autere","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0035","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.2337\/db19-1100","article-title":"Structural alterations in deep brain structures in type 1 diabetes","volume":"69","author":"Filip","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2025.156471_bb0040","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00592-022-01911-1","article-title":"Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathy","volume":"59","author":"D\u2019Addio","year":"2022","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.metabol.2025.156471_bb0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2337\/dc13-1663","article-title":"Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetes","volume":"37","author":"D\u2019Addio","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0050","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.metabol.2016.05.018","article-title":"Role of metabolism in neurodegenerative disorders","volume":"65","author":"Procaccini","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156471_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112043","article-title":"Increased risk of dementia in type 1 diabetes: a systematic review with meta-analysis","volume":"222","author":"Li","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2025.156471_bb0060","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.molmed.2023.09.005","article-title":"Diabetes: a tipping point in neurodegenerative diseases","volume":"29","author":"Santiago","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.metabol.2025.156471_bb0065","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1373\/jalm.2018.027623","article-title":"Differential expression of apoptotic and low-grade inflammatory markers in Alzheimer disease compared to diabetes mellitus type 1 and 2","volume":"3","author":"Alexandraki","year":"2019","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.metabol.2025.156471_bb0070","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1212\/WNL.0b013e31821cccc2","article-title":"Diabetes mellitus and ischemic stroke in the young: clinical features and long-term prognosis","volume":"76","author":"Putaala","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2025.156471_bb0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2337\/dc18-1302","article-title":"Clinical and MRI features of cerebral small-vessel disease in type 1 diabetes","volume":"42","author":"Thorn","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00592-021-01821-8","article-title":"Glycemic control is not related to cerebral small vessel disease in neurologically asymptomatic individuals with type 1 diabetes","volume":"59","author":"Inkeri","year":"2022","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.metabol.2025.156471_bb0085","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S2213-8587(21)00086-3","article-title":"Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC study","volume":"9","author":"Jacobson","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2025.156471_bb0090","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.2337\/db19-0936","article-title":"Acute hyperglycemia increases brain Pregenual anterior cingulate cortex glutamate concentrations in type 1 diabetes","volume":"69","author":"Bolo","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2025.156471_bb0095","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1073\/pnas.1500877112","article-title":"Insulin resistance in brain alters dopamine turnover and causes behavioral disorders","volume":"112","author":"Kleinridders","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.metabol.2025.156471_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000541989","article-title":"Cognitive disorders in type 1 diabetes: role of brain glucose variation, insulin activity, and glucocorticoid exposure","author":"Brossaud","year":"2024","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.metabol.2025.156471_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.16182","article-title":"Patterns of regional brain atrophy and brain aging in middle- and older-aged adults with type 1 diabetes","volume":"6","author":"Habes","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.metabol.2025.156471_bb0110","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.2337\/dc18-0073","article-title":"Long-term glycemic control and dementia risk in type 1 diabetes","volume":"41","author":"Lacy","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2337\/dc19-0906","article-title":"Severe hypoglycemia and cognitive function in older adults with type 1 diabetes: the study of longevity in diabetes (SOLID)","volume":"43","author":"Lacy","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0120","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1210\/jc.2018-01315","article-title":"Cognitive dysfunction in type 1 diabetes mellitus","volume":"104","author":"Shalimova","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156471_bb0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S2213-8587(13)70192-X","article-title":"Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study","volume":"2","author":"Tuligenga","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2025.156471_bb0130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00125-020-05369-0","article-title":"Consequences of recurrent hypoglycaemia on brain function in diabetes","volume":"64","author":"McCrimmon","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2025.156471_bb0135","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/dc21-2438","article-title":"Brain structure among middle-aged and older adults with long-standing type 1 diabetes in the DCCT\/EDIC study","volume":"45","author":"Jacobson","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0140","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/clinem\/dgaa832","article-title":"Structural gray and white matter differences in patients with type 1 diabetes and impaired awareness of hypoglycemia","volume":"106","author":"Stantonyonge","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156471_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001516","article-title":"Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia","volume":"8","author":"Sampedro","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00027","article-title":"Comparison of manual cross-sectional measurements and automatic volumetry of the corpus callosum, and their clinical impact: a study on type 1 diabetes and healthy controls","volume":"11","author":"Claesson","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.metabol.2025.156471_bb0155","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1038\/s41366-022-01222-z","article-title":"Metabolism and memory: alpha-synuclein level in children with obesity and children with type 1 diabetes; relation to glucotoxicity, lipotoxicity and executive functions","volume":"46","author":"Salah","year":"2022","journal-title":"Int J Obes"},{"key":"10.1016\/j.metabol.2025.156471_bb0160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2213-8587(19)30405-X","article-title":"Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression","volume":"8","author":"van Sloten","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2025.156471_bb0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tem.2021.10.008","article-title":"Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline","volume":"33","author":"Little","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156471_bb0170","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neuroscience.2021.03.009","article-title":"SLC40A1 mediates Ferroptosis and cognitive dysfunction in type 1 diabetes","volume":"463","author":"Hao","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.metabol.2025.156471_bb0175","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1007\/s00125-014-3333-6","article-title":"Cerebrospinal fluid levels of Alzheimer\u2019s disease biomarkers in middle-aged patients with type 1 diabetes","volume":"57","author":"Ouwens","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2025.156471_bb0180","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1002\/jcb.28094","article-title":"A shared comparison of diabetes mellitus and neurodegenerative disorders","volume":"120","author":"Morsi","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.metabol.2025.156471_bb0185","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.metabol.2014.09.003","article-title":"Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness","volume":"63","author":"Chiu","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156471_bb0190","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.2337\/db17-1227","article-title":"Islet-derived eATP fuels autoreactive CD8(+) T cells and facilitates the onset of type 1 diabetes","volume":"67","author":"Tezza","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2025.156471_bb0195","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1172\/JCI94524","article-title":"P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes","volume":"128","author":"D\u2019Addio","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156471_bb0200","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1038\/s41598-020-62756-8","article-title":"Peripheral proinflammatory Th1\/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis","volume":"10","author":"Jin","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2025.156471_bb0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12974-022-02446-6","article-title":"The role of Th17 cells\/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A","volume":"19","author":"Fu","year":"2022","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.metabol.2025.156471_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.metabol.2025.156471_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.metabol.2025.156471_bb0220","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41582-024-01046-7","article-title":"Immune mechanisms and shared immune targets in neurodegenerative diseases","volume":"21","author":"Weiner","year":"2025","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.metabol.2025.156471_bb0225","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-immunol-093019-110159","article-title":"Microglia and central nervous system-associated macrophages-from origin to disease modulation","volume":"39","author":"Prinz","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.metabol.2025.156471_bb0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41421-024-00666-z","article-title":"Immunological aspects of central neurodegeneration","volume":"10","author":"Niso-Santano","year":"2024","journal-title":"Cell Discov"},{"key":"10.1016\/j.metabol.2025.156471_bb0235","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3389\/fimmu.2017.01905","article-title":"Neuroinflammation: microglia and T cells get ready to tango","volume":"8","author":"Schetters","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2025.156471_bb0240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tins.2022.08.001","article-title":"How the immune system shapes neurodegenerative diseases","volume":"45","author":"Mason","year":"2022","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.metabol.2025.156471_bb0245","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2025.156471_bb0250","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.metabol.2025.156471_bb0255","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nri.2017.125","article-title":"Microglia and macrophages in brain homeostasis and disease","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.metabol.2025.156471_bb0260","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149229","article-title":"Glia limitans superficialis oxidation and breakdown promote cortical cell death after repetitive head injury","volume":"6","author":"Mason","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.metabol.2025.156471_bb0265","article-title":"Prevention or delay of diabetes and associated comorbidities: standards of care in Diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice C","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0270","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/s12916-024-03763-8","article-title":"The double life of glucose metabolism: brain health, glycemic homeostasis, and your patients with type 2 diabetes","volume":"22","author":"Schwartz","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.metabol.2025.156471_bb0275","article-title":"13. Older adults: standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association pProfessional pPractice C","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0280","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.tem.2016.04.005","article-title":"Type 1 diabetes and dysfunctional intestinal homeostasis","volume":"27","author":"D\u2019Addio","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156471_bb0285","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1111\/j.1600-6143.2010.03309.x","article-title":"Improved function of circulating angiogenic cells is evident in type 1 diabetic islet-transplanted patients","volume":"10","author":"Petrelli","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.metabol.2025.156471_bb0290","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.stem.2015.07.010","article-title":"Circulating IGF-I and IGFBP3 levels control human colonic stem cell function and are disrupted in diabetic enteropathy","volume":"17","author":"D\u2019Addio","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.metabol.2025.156471_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009923","article-title":"Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients\u2019 skin which are normalized by kidney-pancreas transplantation","volume":"5","author":"Folli","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2025.156471_bb0300","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2337\/dc11-1697","article-title":"Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation","volume":"35","author":"Fiorina","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0305","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001493","article-title":"Cognitive outcome after islet transplantation","volume":"9","author":"Mailliez","year":"2023","journal-title":"Transplant Direct"},{"key":"10.1016\/j.metabol.2025.156471_bb0310","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2337\/dc25-0059","article-title":"Impact of islet transplantation on diabetes complications and mortality in patients living with type 1 diabetes","volume":"48","author":"Perrier","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0315","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/ncb2562","article-title":"IKKbeta\/NF-kappaB disrupts adult hypothalamic neural stem cells to mediate a neurodegenerative mechanism of dietary obesity and pre-diabetes","volume":"14","author":"Li","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2025.156471_bb0320","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s42255-021-00345-3","article-title":"POMC neuronal heterogeneity in energy balance and beyond: an integrated view","volume":"3","author":"Quarta","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.metabol.2025.156471_bb0325","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J Clin Invest"},{"issue":"619\u201330","key":"10.1016\/j.metabol.2025.156471_bb0330","article-title":"Nucleus of the solitary tract serotonin 5-HT(2C) receptors modulate food intake","volume":"28","author":"D\u2019Agostino","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2025.156471_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.582825","article-title":"Role of peripheral immune cells-mediated inflammation on the process of neurodegenerative diseases","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2025.156471_bb0340","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.4239\/wjd.v15.i10.2022","article-title":"Immunotherapy in type 1 diabetes: novel pathway to the future ahead","volume":"15","author":"Ray","year":"2024","journal-title":"World J Diabetes"},{"issue":"3","key":"10.1016\/j.metabol.2025.156471_bb0345","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00125-024-06323-0","article-title":"Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab","author":"Galderisi","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2025.156471_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.956907","article-title":"Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects","volume":"13","author":"Chitnis","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2025.156471_bb0355","first-page":"6","article-title":"FDA approves anti-CD3 antibody to delay type 1 diabetes onset","volume":"22","author":"Mullard","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2025.156471_bb0360","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1093\/brain\/awv184","article-title":"Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson\u2019s disease","volume":"138","author":"Jucaite","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.metabol.2025.156471_bb0365","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-019-0213-9","article-title":"Targeting innate immune mediators in type 1 and type 2 diabetes","volume":"19","author":"Donath","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.metabol.2025.156471_bb0370","doi-asserted-by":"crossref","first-page":"eadn2136","DOI":"10.1126\/sciadv.adn2136","article-title":"Monocytes in type 1 diabetes families exhibit high cytolytic activity and subset abundances that correlate with clinical progression","volume":"10","author":"Pant","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.metabol.2025.156471_bb0375","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.cmet.2024.09.003","article-title":"GLP-1 programs the neurovascular landscape","volume":"36","author":"Chen","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2025.156471_bb0380","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s42255-025-01263-4","article-title":"Incretin-based therapeutics for the treatment of neurodegenerative diseases","volume":"7","author":"Vear","year":"2025","journal-title":"Nat Metab"},{"key":"10.1016\/j.metabol.2025.156471_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.metabol.2025.156471_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109952","article-title":"Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson\u2019s and Alzheimer\u2019s disease clinical trials: a revolution in the making?","volume":"253","author":"Holscher","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.metabol.2025.156471_bb0395","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","article-title":"Trial of Lixisenatide in early Parkinson\u2019s disease","volume":"390","author":"Meissner","year":"2024","journal-title":"N Engl J Med"},{"issue":"10479","key":"10.1016\/j.metabol.2025.156471_bb0400","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0140-6736(24)02808-3","article-title":"Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson\u2019s disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial","volume":"405","author":"Vijiaratnam","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2025.156471_bb0405","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2025.156471_bb0410","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/s41586-024-07419-8","article-title":"GLP-1-directed NMDA receptor antagonism for obesity treatment","volume":"629","author":"Petersen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2025.156471_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative disease treatment","volume":"186","author":"Kopp","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.metabol.2025.156471_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1146960","article-title":"Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats","volume":"14","author":"Guo","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2025.156471_bb0425","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/mds.26734","article-title":"Reduced incidence of Parkinson\u2019s disease after dipeptidyl peptidase-4 inhibitors-a nationwide case-control study","volume":"31","author":"Svenningsson","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.metabol.2025.156471_bb0430","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2337\/dc22-1705","article-title":"Association of Sodium-Glucose Cotransporter 2 inhibitors with time to dementia: a population-based cohort study","volume":"46","author":"Wu","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0435","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s11095-022-03302-1","article-title":"Therapeutic potential of Semaglutide, a newer GLP-1 receptor agonist, in abating obesity, non-alcoholic steatohepatitis and neurodegenerative diseases: a narrative review","volume":"39","author":"Mahapatra","year":"2022","journal-title":"Pharm Res"},{"key":"10.1016\/j.metabol.2025.156471_bb0440","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.2337\/dc24-0229","article-title":"Plasma biomarkers of brain injury and their association with brain MRI and cognition in type 1 diabetes","volume":"47","author":"Karger","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0445","doi-asserted-by":"crossref","first-page":"1229509","DOI":"10.3389\/fnins.2023.1229509","article-title":"Patients with type 1 diabetes and albuminuria have a reduced brain glycolytic capability that is correlated with brain atrophy","volume":"17","author":"Vestergaard","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/j.metabol.2025.156471_bb0450","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jdiacomp.2018.12.016","article-title":"Brain spectroscopy reveals that N-acetylaspartate is associated to peripheral sensorimotor neuropathy in type 1 diabetes","volume":"33","author":"Hansen","year":"2019","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.metabol.2025.156471_bb0455","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jdiacomp.2018.04.003","article-title":"Clinically significant cognitive impairment in older adults with type 1 diabetes","volume":"33","author":"Chaytor","year":"2019","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.metabol.2025.156471_bb0460","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/dc17-1955","article-title":"Cognitive function deficits associated with long-duration type 1 diabetes and vascular complications","volume":"41","author":"Musen","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0465","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002557","article-title":"Comparison of cognitive function in older adults with type 1 diabetes, type 2 diabetes, and no diabetes: results from the study of longevity in diabetes (SOLID)","volume":"10","author":"Lacy","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0470","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/5525213","article-title":"Cerebral small vessel disease is associated with smaller brain volumes in adults with type 1 diabetes","volume":"2024","author":"Claesson","year":"2024","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.metabol.2025.156471_bb0475","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012243","article-title":"Association of Type 1 diabetes and hypoglycemic and hyperglycemic events and risk of dementia","volume":"97","author":"Whitmer","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2025.156471_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00440","article-title":"Hematopoietic stem cell gene therapy to halt neurodegeneration","volume":"21","author":"Biffi","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.metabol.2025.156471_bb0485","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-022-00542-y","article-title":"TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target","volume":"17","author":"Li","year":"2022","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.metabol.2025.156471_bb0490","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.metabol.2025.156471_bb0495","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147474","article-title":"The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes","volume":"6","author":"Dong","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.metabol.2025.156471_bb0500","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2337\/dc22-2200","article-title":"Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked, controlled trial","volume":"46","author":"Russell","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2025.156471_bb0505","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.immuni.2022.10.016","article-title":"Emerging roles of innate and adaptive immunity in Alzheimer\u2019s disease","volume":"55","author":"Chen","year":"2022","journal-title":"Immunity"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525003415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525003415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:12:10Z","timestamp":1773951130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049525003415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":101,"alternative-id":["S0026049525003415"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156471","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic and immune dysfunction at the crossroads between type 1 diabetes and neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156471"}}